Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

SLC11A1 promoter gene polymorphisms and fibrosis progression in chronic hepatitis C.

Romero-Gómez M, Montes-Cano MA, Otero-Fernández MA, Torres B, Sánchez-Muñoz D, Aguilar F, Barroso N, Gómez-Izquierdo L, Castellano-Megias VM, Núñez-Roldán A, Aguilar-Reina J, González-Escribano MF.

Gut. 2004 Mar;53(3):446-50.

2.

YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C.

Fontana RJ, Litman HJ, Dienstag JL, Bonkovsky HL, Su G, Sterling RK, Lok AS; HALT-C Trial Group.

Liver Int. 2012 Apr;32(4):665-74. doi: 10.1111/j.1478-3231.2011.02686.x. Epub 2011 Nov 22.

3.

Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C.

Falleti E, Cmet S, Fabris C, Bitetto D, Cussigh A, Fornasiere E, Bignulin E, Feruglio C, Mosanghini E, Fontanini E, Pirisi M, Toniutto P.

Cytokine. 2012 Jan;57(1):68-73. doi: 10.1016/j.cyto.2011.10.018. Epub 2011 Nov 27.

PMID:
22122913
4.

Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection.

Yee LJ, Tang J, Herrera J, Kaslow RA, van Leeuwen DJ.

Genes Immun. 2000 Aug;1(6):386-90.

5.

A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease.

Iwata R, Baur K, Stieger B, Mertens JC, Daly AK, Frei P, Braun J, Vergopoulos A, Stickel F, Sabrane K, Martin IV, Schmitt J, Goetze O, Day CP, Müllhaupt B, Geier A; Swiss Hepatitis C Cohort Study Group.

Clin Sci (Lond). 2011 Apr;120(7):287-96. doi: 10.1042/CS20100246.

PMID:
20883210
6.

SLC11A1 polymorphisms are associated with the risk of chronic obstructive pulmonary disease in a Korean population.

Kim EJ, Kim KM, Park SH, Kim JS, Lee WK, Cha SI, Kim CH, Kang YM, Han SB, Jung TH, Park JY.

Biochem Genet. 2008 Aug;46(7-8):506-19. doi: 10.1007/s10528-008-9166-6. Epub 2008 May 27.

PMID:
18504650
7.

Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels.

Besheer T, Arafa M, El-Maksoud MA, Elalfy H, Hasson A, Zalata K, Elkashef W, Elshahawy H, Raafat D, Elemshaty W, Elsayed E, Zaghloul H, Razek AA, El-Bendary M.

Turk J Gastroenterol. 2018 May;29(3):299-307. doi: 10.5152/tjg.2018.17570.

8.

Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C.

Miyashita M, Ito T, Sakaki M, Kajiwara A, Nozawa H, Hiroishi K, Kobayashi M, Kumada H, Imawari M.

J Viral Hepat. 2012 Sep;19(9):608-14. doi: 10.1111/j.1365-2893.2011.01580.x. Epub 2012 Jan 28.

PMID:
22863264
9.

Genetic susceptibility to Behçet's syndrome is associated with NRAMP1 (SLC11A1) polymorphism in Turkish patients.

Ateş O, Dalyan L, Hatemi G, Hamuryudan V, Topal-Sarikaya A.

Rheumatol Int. 2009 May;29(7):787-91. doi: 10.1007/s00296-008-0763-9. Epub 2008 Nov 8.

PMID:
18998137
10.

IL17A gene polymorphisms: relationship to predisposition for chronic viral hepatitis and progression to liver cirrhosis in kazakh population.

Massabayeva MR, Aukenov NE, Mussazhanova ZB, Saenko VA, Rogounovitch TI, Shaimardanov NK, Kurmanova BR, Barkibaeva NR, Rakhypbekov TK.

Vopr Virusol. 2016;61(5):212-9.

PMID:
29323853
11.

Association of the solute carrier family 11 member 1 gene polymorphisms with susceptibility to leprosy in a Brazilian sample.

Brochado MJ, Gatti MF, Zago MA, Roselino AM.

Mem Inst Oswaldo Cruz. 2016 Feb;111(2):101-5. doi: 10.1590/0074-02760150326. Epub 2016 Jan 26.

12.

The Synergistic Effect of TNFα -308 G/A and TGFβ1 -509 C/T Polymorphisms on Hepatic Fibrosis Progression in Hepatitis C Virus Genotype 4 Patients.

Bader El Din NG, Farouk S, El-Shenawy R, Elhady MM, Ibrahim MK, Dawood RM, Salem AM, El Awady MK.

Viral Immunol. 2017 Mar;30(2):127-135. doi: 10.1089/vim.2016.0083. Epub 2017 Feb 2.

PMID:
28151059
13.

Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C.

Fishman S, Lurie Y, Peretz H, Morad T, Grynberg E, Blendis LM, Leshno M, Brazowski E, Rosner G, Halpern Z, Oren R.

Liver Int. 2006 Apr;26(3):279-84.

PMID:
16584388
14.

[Genetics factors determining predisposition to chronic course of virus hepatitis and fibrosis in liver].

Goncharova IA, Beloborodova EV, Freĭdin MB, Beloborodova EI, Chernogoriuk GE, Puzyrev VP.

Mol Biol (Mosk). 2008 Mar-Apr;42(2):238-41. Russian.

PMID:
18610831
15.

Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.

Radwan MI, Pasha HF, Mohamed RH, Hussien HI, El-Khshab MN.

Cytokine. 2012 Oct;60(1):271-6. doi: 10.1016/j.cyto.2012.05.010. Epub 2012 Jun 6.

PMID:
22682513
16.

Role of functional polymorphisms of NRAMP1 gene for the development of Crohn's disease.

Gazouli M, Atsaves V, Mantzaris G, Economou M, Nasioulas G, Evangelou K, Archimandritis AJ, Anagnou NP.

Inflamm Bowel Dis. 2008 Oct;14(10):1323-30. doi: 10.1002/ibd.20488.

PMID:
18454481
17.

Expression of the SLC11A1 (NRAMP1) 5'-(GT)n repeat: opposite effect in the presence of -237C-->T.

Zaahl MG, Robson KJ, Warnich L, Kotze MJ.

Blood Cells Mol Dis. 2004 Jul-Aug;33(1):45-50.

PMID:
15223010
18.

SLC11A1 gene polymorphisms in Korean patients with Behçet's disease.

Kim SK, Jang WC, Park SB, Park DY, Bang KT, Lee SS, Jun JB, Yoo DH, Chang HK.

Scand J Rheumatol. 2006 Sep-Oct;35(5):398-401.

PMID:
17062442
19.

Tumor necrosis factor-alpha -308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients.

Talaat RM, Esmail AA, Elwakil R, Gurgis AA, Nasr MI.

Chin J Cancer. 2012 Jan;31(1):29-35. doi: 10.5732/cjc.011.10258. Epub 2011 Dec 23.

20.

Promoter polymorphism of SLC11A1 (formerly NRAMP1) confers susceptibility to autoimmune type 1 diabetes mellitus in Japanese.

Takahashi K, Satoh J, Kojima Y, Negoro K, Hirai M, Hinokio Y, Kinouchi Y, Suzuki S, Matsuura N, Shimosegawa T, Oka Y.

Tissue Antigens. 2004 Mar;63(3):231-6.

PMID:
14989712

Supplemental Content

Support Center